BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 762206)

  • 1. Determination of nitrofurantoin (Furadantine) and hydroxymethylnitrofurantoin (Urfadyn) in plasma and urine of man by means of high-performance liquid chromatography.
    Vree TB; Hekster YA; Baars AM; Damsma JE; van der Kleijn E; Bron J
    J Chromatogr; 1979 Jan; 162(1):110-6. PubMed ID: 762206
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative human bioavailability study of macrocrystalline nitrofurantoin and two prolonged-action hydroxymethylnitrofurantoin preparations.
    Guelen PJ; Boerema JB; Vree TB
    Drug Intell Clin Pharm; 1988 Dec; 22(12):959-64. PubMed ID: 3243175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitive determination of nitrofurantoin in human plasma and urine by high-performance liquid chromatography.
    Muth P; Metz R; Siems B; Bolten WW; Vergin H
    J Chromatogr A; 1996 Apr; 729(1-2):251-8. PubMed ID: 9004947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-performance liquid-chromatographic assay for nitrofurantoin in plasma and urine.
    Aufrère MB; Hoener B; Vore ME
    Clin Chem; 1977 Dec; 23(12):2207-12. PubMed ID: 923072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Concentration and antimicrobial activity of nitrofurantoin and hydroxymethylnitrofurantoin in urine].
    Tromp FJ; Dankert J; Remmelts RG; Huizinga T
    Ned Tijdschr Geneeskd; 1976 May; 120(21):911-8. PubMed ID: 1272430
    [No Abstract]   [Full Text] [Related]  

  • 6. High-performance liquid chromatographic assay for the metabolites of nitrofurantoin in plasma and urine.
    Hoener BA; Wolff JL
    J Chromatogr; 1980 May; 182(2):246-51. PubMed ID: 7380917
    [No Abstract]   [Full Text] [Related]  

  • 7. The spectrophotometric determination of nitrofurantoin in blood and urine.
    Harrison J; Lewis DA; Ancill RJ
    Analyst; 1973 Feb; 98(163):146. PubMed ID: 4695327
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluorescence assay of nitrofurantoin with o-aminothiophenol in plasma and urine.
    Watari N; Funaki T; Kaneniwa N
    J Pharm Sci; 1980 Jan; 69(1):106-7. PubMed ID: 7354420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Distribution and kinetics of nitrofurantoin in early pregnancy].
    Amon K; Amon I; Hüller H
    Int J Clin Pharmacol; 1972 Aug; 6(3):218-22. PubMed ID: 4648465
    [No Abstract]   [Full Text] [Related]  

  • 10. [A study of the frequency of vomiting during therapy with Furadantine, Furadantine MC and Urfadyn].
    Beysens AJ; Kock HC
    Pharm Weekbl; 1973 Feb; 108(8):149-52. PubMed ID: 4689668
    [No Abstract]   [Full Text] [Related]  

  • 11. [Contribution to the polarographic determination of nitrofurantoin].
    Faith L; Straková A
    Cesk Farm; 1983 Feb; 32(1):19-22. PubMed ID: 6839369
    [No Abstract]   [Full Text] [Related]  

  • 12. Milk secretion of nitrofurantoin, as a specific BCRP/ABCG2 substrate, in assaf sheep: modulation by isoflavones.
    Pérez M; Real R; Mendoza G; Merino G; Prieto JG; Alvarez AI
    J Vet Pharmacol Ther; 2009 Oct; 32(5):498-502. PubMed ID: 19754918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-Hydroxylation of nitrofurantoin in the rat. A 3-methylcholanthrene-inducible pathway of a relatively nontoxic compound.
    Jonen HG; Oesch F; Platt KL
    Drug Metab Dispos; 1980; 8(6):446-51. PubMed ID: 6109614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quantitative determination of nitrofurantoin in body fluids by direct injection HPLC].
    Ebel S; Liedtke R; Missler B
    Arch Pharm (Weinheim); 1980 Jan; 313(1):95-6. PubMed ID: 7369831
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experience with nitrofurantoin preparations].
    Fussek H
    Wien Med Wochenschr; 1968 Aug; 118(33):668-71. PubMed ID: 5680494
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic active hepatitis due to hydroxymethylnitrofurantoin in a male patient.
    Baetens P; Ramboer C
    Acta Clin Belg; 1984; 39(2):85-91. PubMed ID: 6741394
    [No Abstract]   [Full Text] [Related]  

  • 17. Biopharmaceutics of nitrofurantoin.
    Conklin JD
    Pharmacology; 1972; 8(1):178-81. PubMed ID: 4644646
    [No Abstract]   [Full Text] [Related]  

  • 18. A new urinary antiseptic with prolonged action, urfadyn PL, in the treatment of urinary tract infections.
    Mattelaer JJ
    Acta Urol Belg; 1982 Apr; 50(2):270-5. PubMed ID: 7113858
    [No Abstract]   [Full Text] [Related]  

  • 19. Sustained-release dosage form of nitrofurantoin. Part 2. In vivo urinary excretion in man.
    Ertan G; Karasulu E; Abou-Nada M; Tosun M; Ozer A
    J Microencapsul; 1994; 11(2):137-40. PubMed ID: 8006760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-dependence of renal tubular reabsorption of nitrofurantoin.
    Bräunlich H; Bonow A; Schröter S
    Arch Int Pharmacodyn Ther; 1978 Mar; 232(1):92-101. PubMed ID: 27154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.